Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00316173
Status:
COMPLETED
Last Update Posted:
2012-11-27
First Post:
2006-04-19
Brief Title:
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline